Clinical Trial Results: Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial results on longitudinal endotyping of atopic dermatitis using transcriptomic skin analysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2026-06-04